The BCG vaccine is currently in phase II of a five-year trial, testing the vaccine’s effects on human patients. But lead researcher Dr. Denise Faustman, M.D, Ph.D., is optimistic of the vaccine’s ability to help people. As she said in an interview with Diabetes in Control, “We’re talking about a considerable number of people, 10 million people out there, that it would be unbelievable if we can get to that point where we can say that we have a cure.”